Literature DB >> 8559360

Increased risk of familial late-onset Alzheimer's disease in women.

H Payami1, K Montee, H Grimslid, S Shattuc, J Kaye.   

Abstract

The role of gender in the pathogenesis of Alzheimer's disease (AD) is an important issue that remains controversial. We compared men and women in late-onset familial AD kindreds for the risk of developing AD by studying 26 well-characterized familial AD kindreds from the Oregon Alzheimer Disease Center and, for confirmation, an additional 32 kindreds from the National Cell Repository (NCR) at the Indiana University Alzheimer Disease Center. Comparing women to men, the age-adjusted odds ratio estimates were 3.2 (p = 0.0002) for the Oregon data and 2.3 (p = 0.004) for the NCR data. These results suggest that gender is an independent risk factor for familial late-onset AD and may play a role in the pathogenesis of this disease.

Entities:  

Mesh:

Year:  1996        PMID: 8559360     DOI: 10.1212/wnl.46.1.126

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  Impact of estrogen therapy on Alzheimer's disease: a fork in the road?

Authors:  Roberta D Brinton
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition.

Authors:  Erin E Sundermann; Pauline M Maki; Jeffrey R Bishop
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

Review 3.  New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration.

Authors:  Jill S Goldman
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

4.  The apolipoprotein CI A allele as a risk factor for Alzheimer's disease.

Authors:  S E Poduslo; M Neal; K Herring; J Shelly
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

5.  Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female mice.

Authors:  Russell Palm; Jaewon Chang; Jeffrey Blair; Yoelvis Garcia-Mesa; Hyoung-Gon Lee; Rudy J Castellani; Mark A Smith; Xiongwei Zhu; Gemma Casadesus
Journal:  J Neurochem       Date:  2014-04-02       Impact factor: 5.372

6.  Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women.

Authors:  H Payami; S Zareparsi; K R Montee; G J Sexton; J A Kaye; T D Bird; C E Yu; E M Wijsman; L L Heston; M Litt; G D Schellenberg
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

Review 7.  Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions.

Authors:  Cheryl A Frye
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

8.  ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease.

Authors:  Seong Su Kang; Eun Hee Ahn; Xia Liu; Matthew Bryson; Gary W Miller; David Weinshenker; Keqiang Ye
Journal:  Acta Neuropathol       Date:  2021-04-25       Impact factor: 15.887

Review 9.  Hypothalamic-pituitary-gonadal axis involvement in learning and memory and Alzheimer's disease: more than "just" estrogen.

Authors:  Jeffrey A Blair; Henry McGee; Sabina Bhatta; Russell Palm; Gemma Casadesus
Journal:  Front Endocrinol (Lausanne)       Date:  2015-03-25       Impact factor: 5.555

10.  Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice.

Authors:  Laura Leung; Yaisa Andrews-Zwilling; Seo Yeon Yoon; Sachi Jain; Karen Ring; Jessica Dai; Max Mu Wang; Leslie Tong; David Walker; Yadong Huang
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.